Knockout of insulin and IGF-1 receptors on vascular endothelial cells protects against retinal neovascularization

Tatsuya Kondo, David Vicent, Kiyoshi Suzuma, Masashi Yanagisawa, George L. King, Martin Holzenberger, C. Ronald Kahn

Research output: Contribution to journalArticle

178 Citations (Scopus)

Abstract

Both insulin and IGF-1 have been implicated in control of retinal endothelial cell growth, neovascularization, and diabetic retinopathy. To precisely define the role of insulin and IGF-1 signaling in endothelium in these processes, we have used the oxygen-induced retinopathy model to study mice with a vascular endothelial cell-specific knockout of the insulin receptor (VENIRKO) or IGF-1 receptor (VENIFARKO). Following relative hypoxia, VENIRKO mice show a 57% decrease in retinal neovascularization as compared with controls. This is associated with a blunted rise in VEGF, eNOS, and endothelin-1. By contrast, VENIFARKO mice show only a 34% reduction in neovascularization and a very modest reduction in mediator generation. These data indicate that both insulin and IGF-1 signaling in endothelium play a role in retinal neovascularization through the expression of vascular mediators, with the effect of insulin being most important in this process.

Original languageEnglish (US)
Pages (from-to)1835-1842
Number of pages8
JournalJournal of Clinical Investigation
Volume111
Issue number12
DOIs
StatePublished - Jun 2003

Fingerprint

Retinal Neovascularization
IGF Type 1 Receptor
Endothelial Cells
Insulin-Like Growth Factor I
Insulin
Endothelium
Insulin Receptor
Endothelin-1
Diabetic Retinopathy
Vascular Endothelial Growth Factor A
Blood Vessels
Oxygen
Growth

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Knockout of insulin and IGF-1 receptors on vascular endothelial cells protects against retinal neovascularization. / Kondo, Tatsuya; Vicent, David; Suzuma, Kiyoshi; Yanagisawa, Masashi; King, George L.; Holzenberger, Martin; Kahn, C. Ronald.

In: Journal of Clinical Investigation, Vol. 111, No. 12, 06.2003, p. 1835-1842.

Research output: Contribution to journalArticle

Kondo, Tatsuya ; Vicent, David ; Suzuma, Kiyoshi ; Yanagisawa, Masashi ; King, George L. ; Holzenberger, Martin ; Kahn, C. Ronald. / Knockout of insulin and IGF-1 receptors on vascular endothelial cells protects against retinal neovascularization. In: Journal of Clinical Investigation. 2003 ; Vol. 111, No. 12. pp. 1835-1842.
@article{6691f99b92464a23997b7f40b06dd866,
title = "Knockout of insulin and IGF-1 receptors on vascular endothelial cells protects against retinal neovascularization",
abstract = "Both insulin and IGF-1 have been implicated in control of retinal endothelial cell growth, neovascularization, and diabetic retinopathy. To precisely define the role of insulin and IGF-1 signaling in endothelium in these processes, we have used the oxygen-induced retinopathy model to study mice with a vascular endothelial cell-specific knockout of the insulin receptor (VENIRKO) or IGF-1 receptor (VENIFARKO). Following relative hypoxia, VENIRKO mice show a 57{\%} decrease in retinal neovascularization as compared with controls. This is associated with a blunted rise in VEGF, eNOS, and endothelin-1. By contrast, VENIFARKO mice show only a 34{\%} reduction in neovascularization and a very modest reduction in mediator generation. These data indicate that both insulin and IGF-1 signaling in endothelium play a role in retinal neovascularization through the expression of vascular mediators, with the effect of insulin being most important in this process.",
author = "Tatsuya Kondo and David Vicent and Kiyoshi Suzuma and Masashi Yanagisawa and King, {George L.} and Martin Holzenberger and Kahn, {C. Ronald}",
year = "2003",
month = "6",
doi = "10.1172/JCI200317455",
language = "English (US)",
volume = "111",
pages = "1835--1842",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "12",

}

TY - JOUR

T1 - Knockout of insulin and IGF-1 receptors on vascular endothelial cells protects against retinal neovascularization

AU - Kondo, Tatsuya

AU - Vicent, David

AU - Suzuma, Kiyoshi

AU - Yanagisawa, Masashi

AU - King, George L.

AU - Holzenberger, Martin

AU - Kahn, C. Ronald

PY - 2003/6

Y1 - 2003/6

N2 - Both insulin and IGF-1 have been implicated in control of retinal endothelial cell growth, neovascularization, and diabetic retinopathy. To precisely define the role of insulin and IGF-1 signaling in endothelium in these processes, we have used the oxygen-induced retinopathy model to study mice with a vascular endothelial cell-specific knockout of the insulin receptor (VENIRKO) or IGF-1 receptor (VENIFARKO). Following relative hypoxia, VENIRKO mice show a 57% decrease in retinal neovascularization as compared with controls. This is associated with a blunted rise in VEGF, eNOS, and endothelin-1. By contrast, VENIFARKO mice show only a 34% reduction in neovascularization and a very modest reduction in mediator generation. These data indicate that both insulin and IGF-1 signaling in endothelium play a role in retinal neovascularization through the expression of vascular mediators, with the effect of insulin being most important in this process.

AB - Both insulin and IGF-1 have been implicated in control of retinal endothelial cell growth, neovascularization, and diabetic retinopathy. To precisely define the role of insulin and IGF-1 signaling in endothelium in these processes, we have used the oxygen-induced retinopathy model to study mice with a vascular endothelial cell-specific knockout of the insulin receptor (VENIRKO) or IGF-1 receptor (VENIFARKO). Following relative hypoxia, VENIRKO mice show a 57% decrease in retinal neovascularization as compared with controls. This is associated with a blunted rise in VEGF, eNOS, and endothelin-1. By contrast, VENIFARKO mice show only a 34% reduction in neovascularization and a very modest reduction in mediator generation. These data indicate that both insulin and IGF-1 signaling in endothelium play a role in retinal neovascularization through the expression of vascular mediators, with the effect of insulin being most important in this process.

UR - http://www.scopus.com/inward/record.url?scp=0041743158&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0041743158&partnerID=8YFLogxK

U2 - 10.1172/JCI200317455

DO - 10.1172/JCI200317455

M3 - Article

VL - 111

SP - 1835

EP - 1842

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 12

ER -